These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1980200

  • 1. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
    Tomlinson B, Cruickshank JM, Hayes Y, Renondin JC, Lui JB, Graham BR, Jones A, Lewis AD, Prichard BN.
    Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 3. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
    Rousseau MF, Pouleur H, Debaisieux JC, Van Eyll C, Charlier AA.
    Br J Clin Pharmacol; 1989 Sep; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264
    [Abstract] [Full Text] [Related]

  • 4. Haemodynamics in postural hypotension--effects of the beta-adrenoceptor partial agonist xamoterol, and pindolol.
    Mehlsen J, Trap-Jensen J.
    Eur Heart J; 1990 Apr; 11 Suppl A():56-8. PubMed ID: 1971593
    [Abstract] [Full Text] [Related]

  • 5. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course.
    McMurray J, Lang CC, MacLean D, Struthers AD, McDevitt DG.
    Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047
    [Abstract] [Full Text] [Related]

  • 6. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
    Erlemeier HH, Kupper W, Bleifeld W.
    Cardiology; 1990 Jun; 77(1):30-9. PubMed ID: 1972349
    [Abstract] [Full Text] [Related]

  • 7. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
    Fitzgerald DE, Harry JD.
    Br J Clin Pharmacol; 1989 Jun; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
    [Abstract] [Full Text] [Related]

  • 8. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [Abstract] [Full Text] [Related]

  • 9. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
    Silke B, Hanratty CG, Riddell JG.
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
    [Abstract] [Full Text] [Related]

  • 10. Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension.
    Mehlsen J, Trap-Jensen J.
    Acta Med Scand; 1986 Jun; 219(2):173-7. PubMed ID: 2870611
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y, Sakuma I, Nakao Y, Kanno M.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.
    Kowalski MT, Haworth D, Lu X, Thomson DS, Barnett DB.
    Br J Pharmacol; 1990 Jan; 99(1):27-30. PubMed ID: 2158836
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
    Brodde OE, Schemuth R, Brinkmann M, Wang XL, Daul A, Borchard U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of xamoterol on peripheral blood vessels in healthy subjects.
    Fitzgerald DE.
    Br J Clin Pharmacol; 1989 Jun; 28 Suppl 1(Suppl 1):70S-72S. PubMed ID: 2572259
    [Abstract] [Full Text] [Related]

  • 19. The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
    Hadfield SE, Slee SJ, Snow HM.
    Br J Clin Pharmacol; 1989 Jun; 28 Suppl 1(Suppl 1):78S-81S. PubMed ID: 2572262
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.